Neurocrine Biosciences's annual revenues are $100-$500 million (see exact revenue data) and has 500-1,000 employees. It is classified as operating in the Scientific Research & Development Services industry.
Note: Neurocrine Biosciences's revenues are gauged from an analysis of company filings.
Trademark applications show the products and services that Neurocrine Biosciences is developing and marketing.
Neurocrine Biosciences's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets.
Trademarks may include brand names, product names, logos and slogans.
CAHTALOG Downloadable software; downloadable electronic publications; Downloadable electronic publications, namely newsletters, articles, studies, reports, journals and pamphlets in the field of congenital adrenal hyperplasia medical research; downloadable software app to enable users to access a patient health registry; Downloadable electronic training materials in the field of congenital adrenal hyperplasia
NO ONE EVER SUSPECTS COMT ENZYME providing medical information
Determine whether Neurocrine Biosciences grew or shrank during the last recession. This is useful in estimating the
financial strength and credit risk of the company.
Compare how recession-proof Neurocrine Biosciences is relative to the industry overall.
While a new recession may strike a particular industry, measuring the
industry and company's robustness during the last recession estimates its ability to weather future recessions.
Market Share of Neurocrine Biosciences's Largest Competitors
A competitive analysis shows these companies are in the same general field as Neurocrine Biosciences, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Neurocrine Biosciences.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Neurocrine Biosciences and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.